Lu Gaohua
About Lu Gaohua
Lu Gaohua is a Research Fellow and Director at Bristol Myers Squibb, with extensive experience in drug development and regulatory science from previous roles at GSK, Certara, and RIKEN.
Current Title and Role at Bristol Myers Squibb
Lu Gaohua serves as a Research Fellow and Director at Bristol Myers Squibb. He has been part of the company since October 2020, involving himself in significant research projects. His role focuses on research and development within the biopharmaceutical field. He engages in scientific excellence and innovation across multiple therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis.
Previous Experience at GSK
Before joining Bristol Myers Squibb, Lu Gaohua worked at GSK as a GSK Fellow from 2017 to 2020. He brought extensive experience in drug development and regulatory science to his role. During his tenure at GSK, he contributed to the advancement of multiple therapeutic projects in Stevenage, England, United Kingdom.
Principal Scientist at Certara
From 2010 to 2017, Lu Gaohua held the position of Principal Scientist at Certara in Sheffield, England, United Kingdom. His work concentrated on advanced pharmacokinetic and pharmacodynamic modeling. During these seven years, he contributed substantially to the optimization of clinical trial designs and the improvement of drug development processes through advanced data analytics.
Unit Lead at RIKEN
Lu Gaohua served as a Unit Lead at RIKEN from 2004 to 2010 in Nagoya, Aichi, Japan. Leading a research unit, he made significant contributions to biomedical sciences. His leadership roles at RIKEN allowed him to advance foundational research and contribute to the organization's reputation for scientific excellence.
Educational Background and Academic Achievements
Lu Gaohua's academic journey began at Northeastern University in China, where he earned a Bachelor of Science degree from 1989 to 1993. He then advanced his education at Tokyo Medical and Dental University, achieving a Master’s degree from 1999 to 2001, and a Doctor of Philosophy (PhD) from 2001 to 2004. His strong academic background laid the foundation for his extensive research career.